OVERVIEW

C3G & Immune Complex MPGN Updates 2026 is organized by Columbia University Department of Medicine and will be held on Oct 02, 2026.

Description:
Columbia University Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high-yield challenging scenarios in managing C3G and Immune Complex MPGN disease. The half-day conference course is designed to enhance the knowledge of healthcare professionals on pathogenesis, genetics, pathology, and genetic variants associated with C3G disease. Through lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice. The course is tailored for healthcare providers specializing in Nephrology and addressing these issues and includes talks, Q&A, and panel discussions.

Learning Objectives:

  • Describe the distinct mechanisms underlying C3G and IC-MPGN, focusing on how complement dysregulation and immune complex deposition lead to these diseases.
  • Identify genetic and acquired disruptions in complement regulation and their impact on glomerular function in C3G and IC-MPGN.
  • Discuss recent therapeutic advances targeting complement dysregulation, like iptacopan and pegcetacoplan, and their potential in modifying disease progression.
  • Differentiate primary IC-MPGN from secondary forms associated with systemic diseases, and identify diagnostic criteria for distinguishing these subtypes.
  • Recognize the specific biopsy findings, complement assays, and genetic tests that aid in diagnosing C3G and IC GN.
  • Discuss the prevalence, risk factors, and demographic characteristics associated with C3G and IC-MPGN.

KEY DATES

Registrations Open
04 Jun, 2026
Registrations Open
Event Start Date
02 Oct, 2026
Event Start Date
Event End Date
02 Oct, 2026
Event End Date
Credits

Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163. Professions in scope for this activity are listed below.

Physicians:
Amedco LLC designates this live virtual activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners:
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for 5.5 AANPCP continuing education credits.

Physician Assistants:
The National Commission on Certification Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification for PAs. Amedco LLC designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™ PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • 5.5 AMA PRA Category 1 Credits™
  • 5.5 Continuing Education (CE)
  • TARGET AUDIENCE

    PhysicianNursingPhysician AssistantStudentsNephrologistsResidentsNurse PractitionersFellows

    SPECIALITIES

    Nephrology

    RELATED CONFERENCES & LIVE WEBINARS

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$50.05

    Mar 28, 2022 - Nov 30, 2026 | Webcast

    State required course for Texas
    24 AMA PRA Category 1 Credits™
    ...
    More actions
    US$450

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Arizona
    40.25 AMA PRA Category 1 Credits™
    ...
    More actions
    US$740